Home » Drug Information » Recently Approved Drugs » 1996
Medical Areas: Ophthalmology
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Allergan
Approval Status: Approved September 1996
Treatment Area: open-angle glaucoma and ocular hypertension
Alphagan has been approved for the treatment of open-angle
glaucoma and ocular hypertension.
Alphagan is a selective alpha-2 agonist, which significantly
lowers intraocular pressure with minimal effects on cardiovascular
and pulmonary parameters. Its unique dual mechanism of action
lowers intraocular pressure by reducing aqueous humor production
and increasing uveoscleral outflow.
Glaucoma, an eye disease commonly characterized by excessive
intraocular pressure, is a leading cause of blindness in the
world.
